Search

Search Constraints

You searched for: Author/Creator Matulonis, U A

Search Results

1. 944PQUADRA: A phase II, open-label, single-arm study to evaluate niraparib in patients (pts) with relapsed ovarian cancer (ROC) in 4th or later line of therapy: Results from the tBRCAmut subset. (23rd October 2018)

3. 99PA novel framework for evaluating biomarker response relationships in immuno-oncology (IO). (23rd October 2018)

4. LBA36Association of PD-L1 expression and gene expression profiling with clinical response to pembrolizumab in patients with advanced recurrent ovarian cancer: Results from the phase II KEYNOTE-100 study. (23rd October 2018)

5. Overall survival and updated progression-free survival outcomes in a randomized phase II study of combination cediranib and olaparib versus olaparib in relapsed platinum-sensitive ovarian cancer. (7th February 2019)

6. Safety and dose modification for patients receiving niraparib. (13th August 2018)

7. Safety and dose modification for patients receiving niraparib. (14th May 2018)